GOV.UK
Membership
Membership and minutes for the Commission on Human Medicines and its expert advisory groups.
The Secretary of State for Health and Social Care is looking to appoint one lay and two specialist Commissioners to the Commission on Human Medicines (CHM).
We are looking for skilled communicators with the ability to operate effectively on a national expert scientific committee.
For more information please visit the Centre for Public Appointments.
The Chair and Commissioners are appointed in accordance with the Code of Practice for Ministerial Appointments to Public Bodies, issued by the Commissioner for Public Appointments. The Chair and Commissioners follow a code of practice, in which they are precluded from holding personal interests. Their interests in the pharmaceutical industry are published in the Commission’s annual report each year.
The Commission meets monthly in London. The Commission is supported in its work by Expert Advisory Groups (EAGs), covering various areas of medicine. In addition, the Commission calls on experts not readily available through its membership.
Members and chair
Professor Stuart Ralston MB ChB MD FRCP FMedSci FRSE FFPM (Hon): Arthritis Research UK Professor of Rheumatology, University of Edinburgh, Western General Hospital, Edinburgh (Chair)
Ms Susan Bradford Lay Representative
Professor Jamie Coleman MD MA (Med Ed) FRCP FBPhS Professor in Medical Education / Consultant Clinical Pharmacologist, University of Birmingham
Dr Jamie Fraser BSc MB ChB MRCGP GP Partner, Southside Surgery, Inverness
Professor Jonathan S Friedland MA PhD FRCP FRCPE FRCPI FESCMID FMedSci: Deputy Prinicipal, St. George’s University of London: Hon Consultant in Infectious Diseases St George’s University Hospitals NHS Foundation Trust
Dr Richard Gilson MD FRCP: Associate Professor in Sexual Health and HIV and Honorary Consultant Physician, Central and North West London NHS Foundation Trust. Director, UCL Centre for Clinical Research in Infection and Sexual Health; Deputy Director, Institute for Global Health, University College London
Professor Malcolm R Macleod BSc MBChB MRCP PhD FRCP (Edin): Professor of Neurology and Translational Neurosciences, University of Edinburgh and Honorary Consultant Neurologist, NHS Forth Valley
Dr Rebecca Mann BM BS FRCPCH: Consultant Paediatrician, Taunton and Somerset NHS Foundation Trust
Dr Sarah Meredith: Deputy Director, MRC Clinical Trials Unit and Honorary Senior Lecturer, Department of Primary Care and Population Sciences, University College London
Dr Siraj Misbah MBBS (Hons) MSc FRCP FRCPath: Consultant Clinical Immunologist, Lead for Clinical Immunology, Oxford University Hospitals
Professor Sir Munir Pirmohamed MB ChB (Hons) PhD FRCP FRCP (Edin) FBPhS, FFPM (Hon) FMedSci David Weatherall Chair of Medicine, University of Liverpool, NHS Chair of Pharmacogenetics, Director of the Wolfson Centre for Personalised Medicine, Director of the MRC Centre for Drug Safety Science
Professor Shirley Price MSc, PhD, FBTS, FRSB, ERT, FHEA, FRSC, MBPharmacolSoc Professor of Toxicology, Academic Director, Student Progression and Learning Gain
Professor Kevin M G Taylor BPharm PhD MRPharmS Chair of the British Pharmacopoeia Commission and Professor of Clinical Pharmaceutics, UCL School of Pharmacy, London
Mrs Helen M Ward MSc, BSc (Hons), Senior Fellow HEA, RGN, RCN Nurse Practitioner, PGCEA, PG Cert NMP, Queens Nurse, Advanced Nurse Practitioner
Dr Martin Wilson MRCP (UK) MPhil (Glasgow), FRCP(Edin) Consultant Physician in Care of the Elderly, Raigmore Hospital, Inverness
Summary minutes
Summary minutes are prepared on the basis that no personal, commercial or otherwise confidential information is disclosed.
See the final summary minutes for CHM and EAGs from 2014 onwards, which you can download.
Previous minutes can be seen on the MHRA pages on the National Archives
Meeting dates
2019
| Jan | Feb | March | April | May | June | July | Sept | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 24/25 | 21/22 | 21/22 | 18 | 23/24 | 20/21 | 18/19 | 12/13 | 10/11 | 7/8 | 5/6 |
2018
| Jan | Feb | March | April | May | June | July | Sept | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 18/19 | 15/16 | 15/16 | 19/20 | 24/25 | 21/22 | 19/20 | 13/14 | 11/12 | 8/9 | 6/7 |
Infection EAG
Remit
To advise the Commission on the safety and efficacy of medicines for use in infections including HIV, AIDS and viral hepatitis.
Chair
Professor Jonathan S Friedland MA PhD FRCP FRCPE FRCPI FECCMID FMedSci Deputy Prinicipal, St. George’s University of London: Hon Consultant in Infectious Diseases St George’s University Hospitals NHS Foundation Trust
Members
Professor David Dockrell MB BCh MD FRCPI FRCP (Glas) FACP, Professor of Infection Medicine, University of Edinburgh
Dr Andrew Freedman B.A M.B,B.Chir M.A M.D FRCP FRCP Reader in Infectious Diseases, Cardiff University School of Medicine/ Hon. Consultant Physician, University Hospital of Wales
Dr Richard Gilson MD FRCP Associate Professor in Sexual Health and HIV and Honorary Consultant Physician, Central and North West London NHS Foundation Trust. Director, UCL Centre for Clinical Research in Infection and Sexual Health; Deputy Director, Institute for Global Health, University College London
Dr Richard Hobson MB BS MRCP (UK) FRCPath PhD Consultant Microbiologist and Honorary Senior Lecturer, Harrogate & District NHS Foundation Trust/University of Leeds
Dr Susan Hopkins MB ChB BAO (Hons) BA FRCPI Consultant in Infectious Diseases and Microbiology, Royal Free Hampstead NHS Trust, Healthcare Epidemiologist, Health Protection Agency, Honorary Senior Lecturer, University College London
Dr Katie Jeffery FRCP FRCPath Deputy Director of Infection Prevention and Control, Consultant Microbiologist (Clinical Lead), Oxford University Hospitals NHS Foundation Trust
Dr Hermione Lyall BSc Hons MB ChB Hons MD FRCPCH Consultant in Paediatric Infectious Diseases, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London
Professor Kevin Moore BSc MB BS PhD FRCP Professor of Hepatology, Royal Free Hospital, London
Dr Matthias Schmid MD FRCP DTMH Consultant Physician & Honorary Clinical Senior Lecturer, Head of Department of Infection & Tropical Medicine, Royal Victoria Infirmary
Ms Hilary A Shenton CPFA Lay Representative. Retired Secretary to the School of Medicine, University of Sheffield
Cardiovascular, Diabetes, Renal, Respiratory and Allergy EAG
Remit
To advise CHM on the safety and efficacy of medicines for used for the treatment and prevention of cardiovascular, diabetes, renal, respiratory and allergy diseases.
Chair
Professor Jamie Coleman MD MA (Med Ed) FRCP FBPhS , Professor in Medical Education/Consultant Clinical Pharmacologist, University of Birmingham
Members
Professor Amanda Adler MD, PhD, FRCP, Consultant Physician, Diabetes, Addenbrooke’s Hospital, Cambridge University Hospitals
Prof Iolo J Doull DM MRCP FRCPCH Consultant Respiratory Paediatrician, Children’s Hospital for Wales, Cardiff, Deputy Medical Director Welsh Health Specialised Services Committee
Dr John Firth BA BM ChB DM FRCP Consultant Physician and Nephrologist, Addenbrooke’s Hospital, Cambridge
Dr Andrew Grace MB PhD FRCP FACC FESC Consultant Cardiologist, Papworth and Addenbrooke’s Hospitals Cambridge & Research Group Head, Department of Biochemistry, University of Cambridge
Dr Philip W Ind BA Cantab MB BChir MA Cantab FRCP Consultant Physician and Honorary Senior Lecturer in Respiratory Medicine, Imperial School of Medicine, Hammersmith Hospital
Professor Patrick Mark MB CHB (Hons) PhD FRCP (Glasg) Professor of Nephrology & Honorary Consultant Nephrologist, University of Glasgow and Glasgow Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow
Professor Theresa McDonagh BSc (Hons), MB ChB (Hons), MD (Distinction), FRCP, FESC, FHFA Consultant Cardiologist, King’s College Hospital, London & Professor of Heart Failure King’s College, London
Dr Hilary Pinnock MB ChB (Hons) MRCGP MD Reader, Asthma UK Centre for Applied Research, Allergy and Respiratory Research Group, University of Edinburgh; General Practitioner, Whitstable Medical Practice
Dr Pallav L Shah MD MBBS FRCP Consultant Physician, Royal Brompton Hospital and Chelsea & Westminster Hospital, Reader in Respiratory Medicine, Imperial College
Dr Caroline Vaughan PhD Lay Representative of MHRA EAGS. Trustee and Director of Contact a Family and FamilyLine
Professor Sarah Wild MB BChir MSc PhD FRCPE FFPH, Professor of Epidemiology, Honorary Consultant in Public Health, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh
Meeting dates
2018
| Jan | March | May | July | Sept | Nov |
|---|---|---|---|---|---|
| 16 | 12 | 22 | 16 | 11 | 5 |
Chemistry, Pharmacy and Standards EAG
Remit
To advise the CHM on the quality in relation to safety and efficacy of medicinal products which are the subject of marketing authorisation applications and to advise on such other matters as are referred to it.
Chair
Professor Kevin M G Taylor BPharm PhD FRPharmS Chair of the British Pharmacopoeia Commission and Professor of Clinical Pharmaceutics, UCL School of Pharmacy, London
Members
Dr Majella Lane BSc PhD Senior Lecturer in Pharmaceutics, UCL School of Pharmacy
Professor Graham Buckton BPharm PhD DSc FRPharmS FRSC Emeritus Professor of Pharmaceutics, UCL School of Pharmacy
Professor Brian J Clark MSc PhD CChem FRSC Professor of Pharmaceutical and Biomedical Analysis, Bradford University
Mr V’Iain G Fenton-May BPharm MIPharm FRPharmS Pharmaceutical Microbiologist
Professor Geoffrey W Hanlon BSc PhD MRPharmS Emeritus Professor of Pharmaceutical Microbiology, School of Pharmacy & Bio-Molecular Sciences, University of Brighton
Dr Gillian M Hawksworth MBE PhD FFRPS FRPharmS (Hon) DSc Academic Community Pharmacist, Visiting Fellow Lecturer at University of Huddersfield & Past President of the RPSGB
Miss Carol E Knott MRPharmS MBA MIHM Lay Representative. Director of Windcliff Management Ltd
Mr Robert Lowe BPharmS MRPharmS Practising Hospital Pharmacist, NHS Eastern Region
Professor Christopher Marriott PhD DSc Hon DSc FRPharmS CChem FRSC FRSM (Vice Chair) Emeritus Professor of Pharmaceutics, King’s College, London
Professor Yvonne Perrie BSc Hons MRPharmS FAPS FSB PhD Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde.
Ms Hilary A Shenton CPFA Lay Representative. Retired Secretary to the School of Medicine, University of Sheffield
Professor Michael D Threadgill PGCE MA PhD DSc FRSC CChem Professor Emeritus in Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Visiting Professor IBERS, Aberystwyth University
Professor Peter York PhD BSc DSc FRPharmS CChem FRSC FAAPS Emeritus Professor of Pharmaceutics, Bradford University
Meeting dates
2019
| Jan | Feb | March | April | May | June | July | Sept | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 22 | 19 | 19 | 16 | 21 | 18 | 16 | 10 | 8 | 5 | 3 |
2018
| Jan | Feb | March | April | May | June | July | Sept | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 16 | 13 | 13 | 17 | 22 | 19 | 17 | 11 | 9 | 6 | 4 |
Clinical Trials, Biologicals and Vaccines EAG
Remit
To advise the CHM on:
- first time in human (FTIM) studies with new compounds acting (directly or indirectly) via the immune system with a novel target or a novel mechanism of action or having a secondary potential effect on the immune system via a mechanism of action which currently is not well characterised.
- FTIM studies with novel compounds acting via a possible or likely species specific mechanism
- Any FTIM studies which are otherwise seen as requiring expert advice
- Other clinical trials involving classes of compound where MHRA may wish to seek external expert advice or CHM may wish to have oversight
- Whether a product’s mechanism of action is novel and comes within the scope of the EAG
- Pre-meeting scientific advice documentation for within scope compounds
- Other clinical trials where MHRA may wish to seek advice or where there is a difficult risk benefit balance
- Other clinical trials involving products where a new class safety issue has been identified
- The quality, safety and efficacy of medicinal products of biological or biotechnological origin including vaccines which are the subject of marketing authorisation applications; and to advise on such other matters as are referred to it
Chair
Dr Siraj Misbah MBBS (Hons) MSc FRCP FRCPath, Consultant Clinical Immunologist, Lead for Clinical Immunology, Oxford University Hospitals
Members
Professor Farzin Farzaneh DPhil FRCPath FRSB, Professor of Molecular Medicine, King’s College London, Honorary Consultant in Specialist Medicine, King’s College Hospital NHS Trust
Professor Helen J Lachmann MD FRCP FRCPath (Vice Chair) Reader and Honorary Consultant in Amyloidosis and Renal Medicine, University College London
Professor B Kevin Park BSc PhD FMedSci FRCP (Hon) FBTS Director of MRC Centre for Drug Safety Science, Professor of Pharmacology & Head of Institute of Translational Medicine, University of Liverpool
Professor Andrew Pollard PhD FRCPCH Chair of the Joint Committee on Vaccination and Immunisation; Professor of Paediatric Infection and Immunity, University of Oxford
Dr Robin Thorpe PhD FRCPath Retired, Head, Division of Biotherapeutics, National Institute for Biological Standards and Control (NIBSC)
Professor Marc Turner MBBS PhD MBA FRCP FRCPath FHEA Professor of Cellular Therapy; Medical Director Scottish National Blood Transfusion Service (SNBTS)
Mrs Madeleine Wang BA (Hons) Lay Representative. Patient Advocate
Professor Christopher Weir BSc (Hons) PhD MSc FRSS C.Stat Personal Chair in Medical Statistics and Clinical Trials, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh
Meeting dates
2019
| Jan | Feb | March | April | May | June | July | Sept | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | 18 | 18 | 15 | 20 | 17 | 15 | 9 | 7 | 4 | 2 |
2018
| Jan | Feb | March | April | May | June | July | Sept | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 | 12 | 12 | 16 | 21 | 18 | 16 | 10 | 8 | 5 | 3 |
Gastroenterology, Rheumatology, Immunology and Dermatology EAG
Remit
To advise the CHM on the safety and efficacy of medicines for use in gastroenterological, rheumatological, immunological, and dermatological diseases.
Chair
Professor Anthony G Wilson MB BCH BAO DCH PhD FRCP Professor of Rheumatology, Medical School, University of Sheffield
Members
Dr Michael Ardern-Jones BSc MBBS DPhil FRCP Associate Professor, University of Southampton and Consultant Dermatologist
Mr David Chandler Lay Representative. Chief Executive, Psoriasis and Psoriatic Arthritis Alliance, Hertfordshire
Professor Kevin Moore BSc MB BS PhD FRCP Professor of Hepatology, Royal Free Hospital, London
Professor Qasim Aziz MRCP PhD FRCP Professor of Neurogastroenterology, Director Wingate Institute of Neurogastroenterology, Centre for Neuroscience, Trauma and Surgery, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London
Professor Celia Moss OBE BA(Hons) MB BS MA MRCP DM FRCP MRCPCH Consultant Dermatologist, Birmingham Women’s and Children’s NHS FT, Honorary Professor of Paediatric Dermatology, University of Birmingham
Meeting dates
Medicines for Women’s Health EAG
Remit
To advise the CHM on the safety and efficacy of medicines related to endocrinology and women’s reproductive health from menarche to menopause and conditions related to the menopause, such as osteoporosis. The medicines covered will include medicines for contraception, emergency contraception and termination of pregnancy; medicines for infertility and assisted conception; hormone replacement therapy (HRT) and non-hormonal treatments for osteoporosis.
Chair
Dr Ailsa Gebbie MB ChB FRCOG FRCPE FFSRH Consultant Gynaecologist and Deputy Director, Chalmers Centre, Edinburgh
Members
Professor Philip Hannaford MB ChB DRCOG DCH MD FRCGP FFSRH FFPH, Professor of Primary Care, University of Aberdeen
Ms Linda Pepper BA MA (Education), Independent Consultant: patient and public involvement in healthcare
Professor Siobhan Quenby MBBS BSc MD FRCOG, Professor of Obstetrics, Warwick University
Ms Julia Louise Tassano-Edgecombe, Nurse Consultant, Department of Sexual Health, Royal Berkshire NHS Foundation Trust
Professor Jonathan H Tobias BA (Cantab) MBBS (London) MD (London) PhD (London) FRCP (London). Professor of Rheumatology, University of Bristol; Honorary Consultant Rheumatologist, North Bristol Trust
Dr Diana Wellesley FRCP, Head of Prenatal Genetics, Consultant and Honorary Senior Lecturer in Clinical Genetics, Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton
Meeting dates
Neurology, Pain and Psychiatry EAG
Remit
To advise the CHM on the safety and efficacy of medicines for use in neurological conditions, pain management and psychiatric conditions.
Members
Professor Thomas R. E. Barnes MD FRCPsych DSc Professor of Clinical Psychiatry, Imperial College London
Professor Naomi Fineberg BA Hons MB BS MA MRCPsych Consultant in General Adult Psychiatry, Hertfordshire Partnership NHS
Dr David Hunt MBMS MRCP PhD Honorary Consultant Neurologist/ Wellcome Trust Clinician Scientist, Anne Rawling Regenerative Neurology Clinic, University of Edinburgh
Professor Malcolm R Macleod BSc MBChB MRCP PhD FRCP (Edin) (Vice Chair) Professor of Neurology and Translational Neurosciences, University of Edinburgh and Honorary Consultant Neurologist, NHS Forth Valley
Dr Waqar Rashid MBBS BSc MRCP(UK) PhD Consultant and Honorary Clinical Senior Lecturer in Neurology, Brighton and Sussex University Hospitals NHS Trust, member of the Multiple Sclerosis Society
Dr Fergus Rugg-Gunn MB BS MRCP PhD Consultant Neurologist, National Hospital for Neurology and Neurosurgery, Queen Square, London
Dr Aditya Sharma MBBS MD MRCPsych PhD Consultant (Northumberland Tyne and Wear NHS Foundation Trust) & Honorary Clinical Senior Lecturer (Newcastle University) in Child and Adolescent Psychiatry at Adolescent Bipolar Service
Dr Catherine F Stannard MB ChB FRCA FFPMRCA Consultant in Complex Pain/Pain Transformation Programme Clinical Lead, NHS Gloucestershire CCG
Professor Christopher Weir BSc (Hons) PhD MSc FRSS C.Stat Personal Chair in Medical Statistics and Clinical Trials, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh
Meeting dates
Oncology and Haematology EAG
Remit
To advise the CHM on the safety, quality and efficacy of medicines used in the treatment of malignant disease or blood disorders.
Members
Professor David Bowen MA MB Bchir MD MRCP FRCPath,Consultant Haematologist, Leeds Teaching Hospitals and Honorary Professor of Myeloid Leukaemia Studies, University of Leeds
Professor Stephen Devereux PhD FRCP FRCPath Consultant Haematologist, Kings College Hospital
Dr Hugo Ford MA MB BChir MD FRCP Director of Cancer Services, Cambridge University Hospitals
Dr Chris Gallagher BSc PhD FRCP Consultant Medical Oncologist, St Bartholomew’s Hospital, Barts and the London NHS Trust
Professor Angela E Thomas OBE MB BS PhD FRCPE FRCPath FRCPCH (Acting Chair) Consultant Paediatric Haematologist (Retired), Royal Hospital for Sick Children, Edinburgh
Dr Robert Marcus MA FRCP FRCPath Consultant Haematologist, King’s College Hospital London
Paediatric Medicines EAG
The remit of the EAG is to advise the CHM on the safety, quality and efficacy of medicines for paediatric use, including all matters relating to the implementation of the EU Paediatric Regulation.
Chair
Dr Rebecca Mann BMBS FRCPCH Consultant Paediatrician, Taunton and Somerset NHS Foundation Trust
Members
Dr Eileen M Baildam MB ChB DRCOG DCH RCP FRCP FRCPCH Consultant Paediatric Rheumatologist and Honorary Senior Lecturer, Alder Hey Foundation NHS Trust and University of Liverpool
Dr Helen Burdett MB ChB MRCP FRCA Consultant Anaesthetist, Tunbridge Wells Hospital
Professor J Helen Cross MB ChB PhD FRCP FRCPCH, the Prince of Wales’s Chair of Childhood Epilepsy, Deputy Head of Developmental Neurosciences Programme, UCL Institute of Child Health
Professor Steven Cunningham MBChB PhD FRCPCH (Vice Chair) Consultant and Honorary Professor in Paediatric Respiratory Medicine, NHS Lothian Royal Hospital for Sick Children and University of Edinburgh
Professor Meriel Jenney MBChB MRCP MD FRCPCH Consultant Paediatric Oncologist/Assistant Medical Director (Cancer Services), Children’s Hospital for Wales
Dr Caroline Jones MB ChB FRCPCH MD, Consultant Paediatric Nephrologist, Alder Hey Children’s NHS Foundation Trust
Professor Nigel Klein BSc MBBS MRCP PhD FRCPCH Consultant, Great Ormond Street Hospital for Children NHS Trust; Professor of Infectious Diseases and Microbiology, Institute of Child Health, UCL
Dr Rubin Minhas MB ChB MBA GP Principal
Professor Marie-Louise Newell MB MSc PhD FMedSci Emeritus Professor of Global Health, School of Human Development and Health, Faculty of Medicine, University of Southampton
Ms Sara Payne BA CPE LPC Lay Representative. Solicitor
Professor Heather M Wallace PhD FRCPath FRSC FSB FBPharmacolS FBTS European Registered Toxicologist Professor of Biochemical Pharmacology and Toxicology, Division of Applied Medicine, University of Aberdeen
Dr Morris Zwi MB BCh FRCPsych Consultant Child & Adolescent Psychiatrist & Clinical Lead, Child & Adolescent Mental Health Services, Whittington Health, Clinical Lead for Islington Child & Adolescent Mental Health Services
Mrs Catrin Barker Chief Pharmacist, Pharmacy Department, Alder Hey Children’s NHS FT, Eaton Road, Liverpool
Dr Guido Pieles PhD MD Consultant Congenital Cardiologist Congenital Hear Unit, Bristol Heart Institute
Meeting dates
2018
| Jan | Feb | March | April | May | June | July | Aug | Sept | Oct | Nov |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 | 6 | 6 | 11 | 16 | 12 | 10 | 9 | 4 | 3/30 | 29 |
Patient and Public Engagement EAG
The Commission on Human Medicines is in the process of identifying a replacement for the previous Expert Advisory Group on Patient and Public Engagement. This will include refreshing the Group’s remit and objectives. Further details will be added to this page in due course.
Pharmacovigilance EAG
PEAG now review applications for access to Type II Yellow Card data, the completed application form should be emailed directly to pharmacovigilanceservice@mhra.gov.uk
Remit
To advise the CHM on the following in relation to human medicines including herbal products:
- the public health importance of potential new signals
- the confirmation and quantification of risks identified
- appropriate risk minimisation measures including communications
- design and progress of pharmacovigilance plans
- methodologies for pharmacovigilance.
Chair
Professor Sir Munir Pirmohamed MB ChB (Hons) PhD FRCP FRCP (Edin) FBPhS, FFPM (Hon) FMedSci David Weatherall Chair of Medicine, University of Liverpool, NHS Chair of Pharmacogenetics, Director of the Wolfson Centre for Personalised Medicine, Director of the MRC Centre for Drug Safety Science
Members
Professor Darren Ashcroft BPharm MSc PhD FRPharmS Professor of Pharmacoepidemiology, Division of Pharmacy and Optometry, Manchester University
Professor Ann Daly BA PhD FBPhS Professor of Pharmacogenetics and Associate Dean for Internationalisation (Faculty of Medical Sciences), Institute of Cellular Medicine, Newcastle University
Dr Dan Hawcutt BSc MB ChB MD MRCPCH Senior Lecturer in Paediatric Clinical Pharmacology, Women’s and Children’s Health, Institute of Translational Medicine, University of Liverpool.
Professor Ian J Douglas BSc MSc PhD Senior Lecturer in Pharmacoepidemiology, London School of Hygiene & Tropical Medicine
Dr Karen Miller BSc MBBS DRCOG DCH DFFP FRCGP GP Partner, Adelaide Medical Centre, London
Dr Rupert Payne MB ChB MRCP PhD MRCGP FRCP, Consultant Senior Lecturer in Primary Care, University of Bristol
Ms Christine Randall BPharm MRPharmS, Assistant Director, North West Medicines Information Centre
Dr Ruben Thanacoody MD FRCP FRCP (Edin) Consultant Physician, Royal Victoria Infirmary; Honorary Clinical Senior Lecturer, Institute of Cellular Medicine, Newcastle University
Mr Phil Willan MSc Lay Representative. Member of the Royal College of Physicians (RCP) Patient and Carer Network; Member of the RCP Joint Speciality Committee (JSC) for Renal Medicine, Healthcare Associated Infections Working Group, Specialist Advisory Committee for Renal Medicine, JSC for Allergy and Immunology, Faculty of Forensic and Legal Medicine, Federation CPD Policy Committee and Equality and Diversity Monitoring Committee.
Dr Caroline Vaughan PhD Lay Representative of MHRA EAGS. Governor of the Surrey and Sussex Healthcare NHS Trust
Ms Susan Hunneyball BSc (Hons) Lay Member
Dr Mark Glover BA MA MB BChir MRCP PhD Associate Professor and Honorary Consultant Physician, Clinical Pharmacology and General Medicine, University of Nottingham
Meeting dates
2019
| Jan | Feb | March | April | May | June | July | Aug | Sept | Oct | Nov |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 | 6 | 4 | 1 | 8 | 5 | 3 | 28 | 25 | 23 | 20 |
2018
| Jan | Feb | April | May | June | Aug | Sept | Oct | Nov |
|---|---|---|---|---|---|---|---|---|
| 3/31 | 28 | 4 | 9 | 6/27 | 29 | 26 | 24 | 21 |
Type II Yellow Card data
PEAG now review applications for access to Type II Yellow Card data, the completed application form should be emailed directly to pharmacovigilanceservice@mhra.gov.uk
Sodium Valproate Expert Working Group
Terms of reference of the Sodium Valproate expert Working Group
- To review the current risk minimisation in place and possible reasons for lack of effectiveness.
- To consider further regulatory measures required to minimize the risk of valproate use in pregnancy including, but not limited to, a contraindication for use in pregnancy in girls and women without effective contraception and a formal Pregnancy Prevention Program.
- To consider other measures required across the healthcare system to ensure compliance with regulatory position in clinical practice (e.g. shared care agreements, registries.
Chair
Professor Sir Munir Pirmohamed MB ChB (Hons) PhD FRCP FRCP (Edin) FBPhS, FFPM (Hon) FMedSci David Weatherall Chair of Medicine, University of Liverpool, NHS Chair of Pharmacogenetics, Director of the Wolfson Centre for Personalised Medicine, Director of the MRC Centre for Drug Safety Science
Members
Professor J Helen Cross OBE MB ChB PhD FRCP FRCPCH The Prince of Wales’s Chair of Childhood Epilepsy, Deputy Head of Developmental Neurosciences Programme, UCL Institute of Child Health
Dr Martin Duerden B Med Sci, MB BS, DRCOG, Dip Ther, DPH, FRCGP Member of National Stakeholder Platform, Honorary Senior Research Fellow, Centre for Health Economics and Medicines Evaluation, Bangor University
Professor Jayne Lawrence Professor of Biophysical Pharmaceutics, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester University and Visiting Professor of Biophysical Pharmaceutics, Institute of Pharmaceutical Science, King’s College London
Dr John Paul Leach Honorary Associate Clinical Professor, School of Medicine, Dentistry and Nursing, University of Glasgow, Elected Member of the Association of British Neurologists (ABN)
Dr Janine Lynch BHSCT Psychiatrist, Belfast Health & Social Care Trust
Dr Rebecca Mann BMBS FRCPCH Consultant Paediatrician, Taunton and Somerset NHS Foundation Trust
Dr Karen Miller BSc MBBS DRCOG DCH DFFP FRCGP GP Partner, Adelaide Medical Centre, London
Professor Catherine Nelson-Piercy MBBSMA, FRCP, FRCOG Professor of Obstetric Medicine and Consultant Obstetric Physician, Guy’s & St Thomas’ Foundation Trust
Professor David G C Owens MD (Hons) FRCP FRCPsych Professor of Clinical Psychiatry, Edinburgh University
Ms Clare Pelham Chief Executive of the Epilepsy Society
Dr Fergus Rugg-Gunn MB BS MRCP PhD Consultant Neurologist, National Hospital for Neurology and Neurosurgery, Queen Square, London
Ms Laura Russell Senior Policy and Public Affairs Officer Family Planning Association
Professor Philip Smith Consultant Neurologist, Cardiff School of Medicine and former President of the Association of British Neurologists (ABN)
Mrs Madeleine Wang BA (Hons) Lay Representative. Patient Advocate
Invited expert
Professor Thomas R. E. Barnes MD FRCPsych DSc Professor of Clinical Psychiatry, Imperial College London
Opioids Expert Working Group
Terms of reference
The review will:
- consider the current data on the utilisation of opioid-containing medicines in the UK, both prescribed and over the counter
- examine whether the risk minimisation measures implemented for over the counter and prescription opioids have been effective or whether further measures are required
- consider the benefit/risk of opioid-containing medicines in particular for non-cancer indications, taking into account alternatives
- make recommendations for regulatory action to better support appropriate use of prescription opioids, such as relevant changes to the Summary of Product Characteristics and Patient Information Leaflets, product labelling and packaging, and any other risk minimisation measures
Chair
Professor Jamie Coleman MD MA (Med Ed) FRCP FBPhS Professor in Medical Education / Consultant Clinical Pharmacologist, University of Birmingham
Members
Dr Eileen M Baildam MB ChB DRCOG DCH RCP FRCP FRCPCH Consultant Paediatric Rheumatologist and Honorary Senior Lecturer, Alder Hey Foundation NHS Trust and University of Liverpool
Dr Helen Burdett MB ChB MRCP FRCA Consultant Anaesthetist, Tunbridge Wells Hospital
Dr Lesley Colvin Chair in Pain Medicine, University of Dundee/ Consultant in Anaesthesia & Pain Medicine, NHS Tayside, Deputy Head of Division, Population Health and Genomics, Hon. Professor in Pain Medicine, University of Edinburgh
Professor Peter Crome MD PhD DSc FRCP FFPM FBPharmacolS Emeritus Professor, Keele University, Honorary Professor, UCL
Dr Jamie Fraser BSc MB ChB MRCGP GP Partner, Southside Surgery, Inverness
Professor Philip Hannaford MB ChB DRCOG DCH MD FRCGP FFSRH FFPH Professor of Primary Care, University of Aberdeen
Dr Karen Miller BSc MBBS DRCOG DCH DFFP FRCGP GP Partner, Adelaide Medical Centre, London (Apologies)
Professor David G C Owens MD (Hons) FRCP FRCPsych Professor of Clinical Psychiatry, Edinburgh University
Dr Catherine F Stannard MB ChB FRCA FFPMRCA Consultant in Complex Pain/Pain Transformation Programme Clinical Lead, NHS Gloucestershire CCG (also sitting on PHE review board)
Professor Ash Soni OBE FFRPS FRPharmS LPN Pharmacy Chair (London); Executive & Council Member, National Association of Primary Care; English Pharmacy Board Member, Royal Pharmaceutical Society; Pharmacy Clinical Network Lead, Lambeth CCG
Mr Steve Taylor Programme Manager, PHE Alcohol, Drugs, Tobacco & Justice
Dr J P Thompson BMedSci MBChB FRCP FBTS FEAPCCT Clinical Senior Lecturer, Department of Pharmacology, Therapeutics & Toxicology, Cardiff University, and Director NPIS Cardiff Unit
Mrs Madeleine Wang BA (Hons) Lay Representative. Patient Advocate
Mrs Helen M Ward MSc, BSc (Hons), Senior Fellow HEA, RGN, RCN Nurse Practitioner, PGCEA, PG Cert NMP Queens Nurse, Advanced Nurse Practitioner
Professor Christopher Weir BSc (Hons) PhD MSc FRSS C.Stat C. Sci Personal Chair in Medical Statistics and Clinical Trials, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh
Dr Frances Williams BSc MBBS MRCP PhD CCST FRCP (Edin) Reader in Genetic Epidemiology and Hon Consultant Rheumatologist, King’s College London
Observer
Mr Steve Taylor Programme Manager, PHE Alcohol, Drugs, Tobacco & Justice